MarketCapExport financials
Westlake Chemical Partners LP (WLKP)
The export includes the complete available history of financial statements and ratios. Numbers are provided in full, without million or billion abbreviations, in their original reporting units.
CSV downloads as a ZIP archive with one file for each report and frequency.
Facebook
X
Telegram
Westlake Chemical Partners LP Income Statement 2025-2011 | WLKP
Brief overview of revenue and earnings at Westlake Chemical Partners LP
The comparison covers a five-year financial horizon. Revenue reported by Westlake Chemical Partners LP was $967 million at the beginning of the period and $1.2 billion at the end. The total change was +20.7%, with a CAGR of approximately 3.8%. The business did not achieve meaningful top-line expansion.
Gross profit was 379 million dollars at the start and 348 million dollars at the end of the period (−8.2%). Cost of revenue developed less favorably than sales and pressured gross profitability. The gross margin was 39.2% at the start and 29.8% at the end. The margin decline reflects a less favorable sales-and-cost structure.
EBITDA changed from $456 million to $448 million (−1.9%). EBITDA underperformed the top-line trend. EBITDA margin moved from 47.2% to 38.4%. Operating return per unit of revenue declined.
The five-year change in net income was −26.4%: from 66.2 million dollars to 48.7 million dollars. Profit pressure may reflect higher operating, financing, or tax costs.
Overall conclusion
The current trajectory does not yet confirm a sustainable recovery. The weaker side of the profile includes lower net income, a softer top-line trend and weaker operating efficiency. Investors should continue to monitor margins, costs, and earnings quality.
Annual Income Statement Westlake Chemical Partners LP
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
- | - | - | - | 912 M | 748 M | - | - | - | - | - | 643 M | - | - | - |
Shares |
- | - | - | - | 35.2 M | 35.2 M | - | - | - | - | 25.4 M | 25.4 M | - | - | - |
Historical Prices |
22 | 23.2 | 22.2 | 22.7 | 25.9 | 21.2 | 21.5 | 18.2 | 17.6 | 14.2 | 13.6 | 17 | - | - | - |
Net Income |
48.7 M | 62.4 M | 54.3 M | 64.2 M | 82.5 M | 66.2 M | 61 M | 49.3 M | 48.7 M | 40.9 M | 39.8 M | 375 M | 547 M | 396 M | 247 M |
Revenue |
1.17 B | 1.14 B | 1.19 B | 1.59 B | 1.21 B | 967 M | 1.09 B | 1.29 B | 1.17 B | 987 M | 1.01 B | 1.75 B | 2.13 B | 2.25 B | 2.25 B |
Cost of Revenue |
819 M | 717 M | 803 M | 1.22 B | 773 M | 588 M | 712 M | 908 M | 769 M | 595 M | - | - | - | - | - |
Gross Profit |
348 M | 419 M | 387 M | 377 M | 442 M | 379 M | 379 M | 377 M | 404 M | 391 M | 383 M | 746 M | 873 M | 636 M | 409 M |
Operating Income |
320 M | 390 M | 358 M | 348 M | 411 M | 353 M | 350 M | 350 M | 374 M | 366 M | 359 M | 717 M | - | - | - |
Interest Expense |
- | - | - | - | - | - | - | - | - | - | - | 189 K | - | - | - |
EBITDA |
448 M | 502 M | 468 M | 469 M | 520 M | 456 M | 457 M | 458 M | 488 M | 465 M | 441 M | 794 M | 921 M | 676 M | 442 M |
Operating Expenses |
28.3 M | 28.5 M | 29.8 M | 29.7 M | 31 M | 25.9 M | 29.3 M | 27.6 M | 29.3 M | 24.9 M | 23.5 M | 29.3 M | 25.5 M | 24.1 M | 24.3 M |
General and Administrative Expenses |
28.3 M | 28.5 M | 29.8 M | 29.7 M | 31 M | 25.9 M | 29.3 M | 27.6 M | 29.3 M | 24.9 M | 23.6 M | 29.3 M | - | - | - |
Annual performance
Select metrics to display
All numbers in USD currency
Quarterly Income Statement Westlake Chemical Partners LP
| 2026-Q3 | 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 32.3 M | 2.2 K | 32.2 M | 32.2 M | 32.2 M | 1.29 M | 27.2 M | 27.1 M | 27.1 M | - | 27.1 M | 27.1 M | 27.1 M | - | 27.1 M | 27.1 M | 27.1 M | - | 27.1 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income |
90.9 M | 82.4 M | 81.7 M | 84.3 M | 86.2 M | 85.8 M | 42.3 M | 87.4 M | 104 M | 88 M | 89.6 M | 87.1 M | 80.9 M | 75.3 M | 91.5 M | 91.3 M | 78.3 M | 84.4 M | 80.8 M | 138 M | 66.1 M | 120 M | 76.6 M | 75.1 M | 91.8 M | 80.4 M | 93.8 M | 91.9 M | 82.5 M | 80.1 M | 78.4 M | 81.6 M | 83.8 M | 84.5 M | 80.7 M | 98.3 M | 82.2 M | 86.5 M | 86 M | 93.6 M | 75.9 M | 81.2 M | 103 M | 91.2 M | 87 M | 87.2 M | 88.4 M | 93.9 M | 118 M | 154 M | 144 M | - | 402 M | 149 M | - | - | - | - | - | - | - | - | - |
Revenue |
314 M | 297 M | 306 M | 323 M | 309 M | 297 M | 238 M | 290 M | 277 M | 284 M | 285 M | 297 M | 322 M | 264 M | 257 M | 323 M | 364 M | 365 M | 291 M | 318 M | 248 M | 241 M | 220 M | 246 M | 218 M | 227 M | 215 M | 273 M | 217 M | 230 M | 257 M | 336 M | 313 M | 254 M | 235 M | 309 M | 258 M | 241 M | 213 M | 247 M | 194 M | 182 M | 231 M | 213 M | 208 M | 205 M | 209 M | 204 M | 290 M | 415 M | - | - | - | 525 M | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
211 M | 202 M | 212 M | 226 M | 209 M | 200 M | 184 M | 191 M | 160 M | 183 M | 182 M | 197 M | 229 M | 176 M | 202 M | 269 M | 325 M | 351 M | 271 M | 183 M | 218 M | 191 M | 181 M | 161 M | 132 M | 148 M | 147 M | 169 M | 157 M | 178 M | 208 M | 242 M | 270 M | 205 M | 192 M | 198 M | 201 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
104 M | 94.8 M | 93.8 M | 96.8 M | 99.4 M | 97.5 M | 54.1 M | 98.6 M | 117 M | 101 M | 102 M | 101 M | 93 M | 87.7 M | 106 M | 98.1 M | 90.5 M | 97.3 M | 91.4 M | 147 M | 75.9 M | 131 M | 87.7 M | 84.9 M | 100 M | 90 M | 104 M | 104 M | 93.2 M | 92 M | 90.7 M | 93.6 M | 93.9 M | 97.1 M | 92.5 M | 111 M | 95.4 M | 99.6 M | 98 M | 106 M | 86.8 M | 88.4 M | 110 M | 98 M | 94.1 M | 94.5 M | 96.2 M | 102 M | 165 M | 247 M | - | - | - | 238 M | - | - | - | - | - | - | - | - | - |
Operating Income |
95.6 M | 87.3 M | 86.6 M | 89.8 M | 92 M | 91.2 M | 46.6 M | 92 M | 110 M | 93.6 M | 95.1 M | 92.8 M | 86.2 M | 80.5 M | 98.2 M | 95.3 M | 81.8 M | 87.4 M | 83.2 M | 141 M | 68.1 M | 123 M | 79 M | 77.6 M | 94.1 M | 83.9 M | 97.4 M | 95.8 M | 86.4 M | 84.3 M | 83.7 M | 86.5 M | 88 M | 89.7 M | 85.4 M | 103 M | 88.6 M | 92.7 M | 90.1 M | 98.6 M | 81 M | 82.5 M | 104 M | 92.3 M | 88.3 M | 88.5 M | 90.2 M | 95.5 M | 156 M | 240 M | - | - | - | 231 M | - | - | - | - | - | - | - | - | - |
EBITDA |
116 M | 110 M | 109 M | 112 M | 114 M | 113 M | 67.4 M | 113 M | 131 M | 115 M | 117 M | 114 M | 108 M | 101 M | 119 M | 119 M | 105 M | 111 M | 107 M | 164 M | 91.1 M | 146 M | 102 M | 100 M | 117 M | 107 M | 120 M | 118 M | 109 M | 107 M | 106 M | 108 M | 110 M | 112 M | 108 M | 125 M | 112 M | 115 M | 114 M | 123 M | 101 M | 99.6 M | 121 M | 109 M | 105 M | 105 M | 106 M | 110 M | 171 M | 256 M | - | - | 14.6 M | 267 M | - | - | - | - | - | - | - | - | - |
Operating Expenses |
8.34 M | 7.49 M | 7.19 M | 7.05 M | 7.44 M | 6.3 M | 7.47 M | 6.56 M | 7.25 M | 7.6 M | 7.08 M | 7.87 M | 6.74 M | 7.23 M | 7.91 M | 2.85 M | 8.68 M | 9.92 M | 8.23 M | 6.28 M | 7.79 M | 8.27 M | 8.67 M | 7.3 M | 6.26 M | 6.14 M | 6.2 M | 7.84 M | 6.82 M | 7.64 M | 6.97 M | 7.17 M | 5.91 M | 7.38 M | 7.13 M | 7.74 M | 6.8 M | 6.89 M | 7.83 M | 7.15 M | 5.79 M | 5.85 M | 6.1 M | 5.72 M | 5.83 M | 6 M | 6 M | 6.45 M | 8.86 M | 6.16 M | - | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
8.34 M | 7.49 M | 7.19 M | 7.05 M | 7.44 M | 6.3 M | 7.47 M | 6.56 M | 7.25 M | 7.6 M | 7.08 M | 7.87 M | 6.74 M | 7.23 M | 7.91 M | 2.85 M | 8.68 M | 9.92 M | 8.23 M | 6.28 M | 7.79 M | 8.27 M | 8.67 M | 7.3 M | 6.26 M | 6.14 M | 6.2 M | 7.84 M | 6.82 M | 7.64 M | 6.97 M | 7.17 M | 5.91 M | 7.38 M | 7.13 M | 7.74 M | 6.8 M | 6.89 M | 7.83 M | 7.15 M | 5.79 M | 5.85 M | 6.1 M | 5.72 M | 5.83 M | 6 M | 6 M | 6.45 M | 8.86 M | 6.16 M | - | - | - | 6.76 M | - | - | - | - | - | - | - | - | - |
Quarterly performance
Select metrics to display
All numbers in USD currency
The income statement is one of the three key financial reports of a company Westlake Chemical Partners LP (alongside the balance sheet and the cash flow statement). It shows how the company makes money and what its expenses are:
- How much revenue the company earned
- How much it spent on production, personnel, marketing, taxes, etc.
- What profit remained in the end
Analyzing the income statement helps an investor understand whether the business generates stable and growing profits, how effectively the company controls its expenses, and whether it is capable of generating income in the future. Additionally, this analysis shows how the company copes with crises and economic cycles, and allows assessing the potential for stock price growth and dividend payments.
Features- The income statement may include both recurring and one-time items (for example, profit from the sale of assets). It is necessary to separate core metrics from one-off events for accurate analysis.
- Companies often publish interim reports (e.g., quarterly), which allows for more timely tracking of trends.
- A combined analysis of the income statement with the balance sheet and cash flow statement provides a comprehensive view of the company’s financial health.
Reports on the profits and losses of other stocks in the Chemicals industry
| Issuer | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|
 |
Казаньоргсинтез
KZOS
|
- | - | - |  Russia |
 |
Methanex Corporation
MEOH
|
$ 68.12 | 2.45 % | $ 4.94 B |  Canada |
 |
DuPont de Nemours
DD
|
$ 156.26 | 0.72 % | $ 65.2 B |  USA |
 |
Куйбышевазот
KAZT
|
- | - | - | Russia |
 |
Braskem S.A.
BAK
|
$ 1.12 | -0.45 % | $ 462 M |  Brasil |
 |
Роллман
RLMN
|
- | - | - | Russia |
 |
Huntsman Corporation
HUN
|
$ 9.5 | -0.42 % | $ 1.64 B | USA |
 |
Univar Solutions
UNVR
|
- | -0.01 % | $ 5.99 B | USA |
 |
Adicet Bio
ACET
|
$ 2.98 | -0.5 % | $ 20.5 M | USA |
 |
Tronox Holdings plc
TROX
|
$ 2.85 | 4.98 % | $ 452 M | USA |
 |
Air Products and Chemicals
APD
|
$ 312.0 | 0.3 % | $ 69.5 B | USA |
 |
Dow
DOW
|
$ 31.49 | 1.71 % | $ 22.4 B | USA |
 |
Celanese Corporation
CE
|
$ 48.7 | -0.1 % | $ 5.33 B | USA |
 |
FutureFuel Corp.
FF
|
$ 3.12 | -38.46 % | $ 137 M | USA |
 |
AdvanSix
ASIX
|
$ 15.38 | -1.6 % | $ 414 M | USA |
 |
Ashland Global Holdings
ASH
|
$ 76.91 | -1.02 % | $ 3.54 B | USA |
 |
LSB Industries
LXU
|
$ 11.12 | 3.49 % | $ 799 M | USA |
 |
Eastman Chemical Company
EMN
|
$ 65.46 | 0.11 % | $ 7.51 B | USA |
 |
Rayonier Advanced Materials
RYAM
|
$ 5.59 | -1.76 % | $ 373 M | USA |
 |
Sociedad Química y Minera de Chile S.A.
SQM
|
$ 54.42 | -4.02 % | $ 15.5 B |  Chile |
 |
Molecular Data
MKD
|
- | 2.5 % | $ 2.3 M |  China |
 |
Ciner Resources LP
CINR
|
- | 0.81 % | $ 344 M | USA |
 |
Valhi
VHI
|
$ 16.26 | 0.25 % | $ 463 M | USA |
 |
Minerals Technologies
MTX
|
$ 61.87 | -1.15 % | $ 1.94 B | USA |
 |
Нижнекамскнефтехим
NKNC
|
- | - | - | Russia |